Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells is Associated with a Good Prognosis and Infiltrating Lymphocytes

Triple negative breast cancer (TNBC) is a subtype with heterogeneous patient outcomes. Approximately forty percent of patients experience rapid relapse, while the remaining patients have long-term disease-free survival. To determine if there are molecular differences between primary tumors that pred...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Immunol Res
Hlavní autoři: Forero, Andres, Li, Yufeng, Chen, Dongquan, Grizzle, William E., Updike, Katherine L., Merz, Natalie D., Downs-Kelly, Erinn, Burwell, Todd C., Vaklavas, Christos, Buchsbaum, Donald J., Myers, Richard M., LoBuglio, Albert F., Varley, Katherine E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878913/
https://ncbi.nlm.nih.gov/pubmed/26980599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0243
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky